Details of the Drug

General Information of Drug (ID: DMTT74E)

Drug Name

CPCB-RPE1

Indication

Disease Entry	ICD 11	Status	REF
Dry age-related macular degeneration	9B75	Phase 1/2	[1]
------------------------------------------------------------------------------------

Drug Type

Cell therapy

Cross-matching ID

References

1	ClinicalTrials.gov (NCT02590692) Study of Subretinal Implantation of Human Embryonic Stem Cell-Derived RPE Cells in Advanced Dry AMD. U.S. National Institutes of Health.